Dow Down 0.06% Nasdaq Up 0.27%

PDL BioPharma, Inc. (PDLI)

-NasdaqGS
2.94 Down 0.03(0.84%) 9:50AM EST - Nasdaq Real Time Price
Prev Close:2.96
Open:2.89
Bid:2.92 x 1900
Ask:2.93 x 3000
1y Target Est:5.25
Beta:0.660985
Next Earnings Date:22-Feb-16PDLI Earnings announcement
Day's Range:2.89 - 2.96
52wk Range:2.58 - 7.43
Volume:221,692
Avg Vol (3m):2,381,250
Market Cap:480.09M
P/E (ttm):1.76
EPS (ttm):1.67
Div & Yield:0.20 (6.85%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
PDLIDown 0.84%480.09M
AMGNUp 0.73%108.61B
XOMAUp 4.33%95.06M
SGENUp 1.33%4.15B

Key Statistics

Forward P/E (1 yr):4.19
P/S (ttm):0.98
Ex-Dividend Date:02-Mar-16

Analysts

Annual EPS Est (Dec-15) :1.94
Quarterly EPS Est (Dec-15) :0.54
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):0.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

PDL BioPharma, Inc. manages a portfolio of patents and royalty assets in the United States and Europe. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback